Loading…
Integra LifeSciences Holdings Corporation is projected to rise to $16.80 by 2027, a +11% move from its current price of $15.19. IART is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.72 | $15.19 | $15.66 | -0.03% |
| May 30 | $14.53 | $15.18 | $15.86 | -0.06% |
| May 31 | $14.39 | $15.18 | $16.01 | -0.08% |
| Jun 1 | $14.27 | $15.17 | $16.14 | -0.11% |
| Jun 2 | $14.16 | $15.17 | $16.25 | -0.14% |
| Jun 3 | $14.06 | $15.16 | $16.36 | -0.17% |
| Jun 4 | $13.97 | $15.16 | $16.45 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.97 | $15.16 | $16.45 | -0.19% |
| Week 2 | $13.48 | $15.13 | $16.98 | -0.39% |
| Week 3 | $13.11 | $15.10 | $17.40 | -0.58% |
| Week 4 | $12.80 | $15.07 | $17.75 | -0.77% |
| Week 5 | $12.53 | $15.04 | $18.06 | -0.96% |
| Week 6 | $12.29 | $15.01 | $18.34 | -1.15% |
| Week 7 | $12.07 | $14.99 | $18.60 | -1.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments and offers its products directly through various salesforces and other distribution channels to hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey; it was formerly known as Integra LifeSciences Corp.
and changed its name to Integra LifeSciences Holdings Corporation in June 1995.
Integra LifeSciences Holdings Corporation (IART) is a healthcare company in the medical devices space, focusing on neurosurgery, neurocritical care, and otolaryngology products. The stock trades with a current price of $15.10 and a market cap of $1.17B, ranking 2407 by market capitalization. The near-term and long-term outlook is captured in a multi-year forecast showing modest near-term levels and strong longer-term upside.
A major floor 45.7% below — a decisive break under it would weaken the trend.
The nearest floor, 33.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 24.2% above — clearing it would confirm fresh momentum.
Key IART support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IART market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.20 | Sell | $15.05 | Buy |
| MA 10 | $14.80 | Buy | $14.68 | Buy |
| MA 20 | $13.63 | Buy | $13.80 | Buy |
| MA 50 | $11.41 | Buy | $12.37 | Buy |
| MA 100 | $11.39 | Buy | $11.99 | Buy |
| MA 200 | $12.57 | Buy | $12.88 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.02 | Sell |
| Stoch RSI (14) | 41.80 | Neutral |
| CCI (20) | 81.20 | Neutral |
| Williams %R (14) | -10.93 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 9.12 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 89.07 | Sell |
| TRIX (15) | 1.38 | Buy |
| Awesome (5,34) | 2.80 | Buy |
| Ultimate (7,14,28) | 74.92 | Sell |
| Momentum (10) | 1.42 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 15.39 | Sell |
| ADX (14) | 33.71 | Buy |
| ATR (14) | 0.36 | Info |
The current technical setup shows bullish sentiment with an RSI of 70, supported by a 50-day simple moving average of $11.16 and a 200-day simple moving average of $12.54. The stock is trading with support at $10.08 and resistance at $15.39, placing the current price near the upper end of recent activity. Over the last 30 days, the range has been $12.16 to $18.74, indicating notable near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.90 | $15.19 | $21.23 | 0% | Neutral | |
| $13.16 | $16.80 | $22.83 | +11% | Neutral | |
| $13.70 | $18.05 | $25.51 | +19% | Neutral | |
| $16.57 | $22.41 | $32.68 | +48% | Bullish | |
| $19.63 | $27.17 | $40.68 | +79% | Bullish | |
| $21.00 | $29.69 | $45.49 | +95% | Bullish | |
| $20.49 | $29.56 | $46.23 | +95% | Bullish | |
| $21.14 | $31.08 | $49.53 | +105% | Bullish | |
| $22.10 | $33.08 | $53.62 | +118% | Bullish | |
| $24.06 | $36.63 | $60.34 | +141% | Bullish | |
| $29.88 | $49.22 | $86.67 | +224% | Bullish | |
| $65.40 | $123.68 | $239.95 | +714% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.90 | $15.19 | $17.92 | +0.00% |
| June 2026 | $12.98 | $15.29 | $18.46 | +0.63% |
| July 2026 | $12.46 | $14.81 | $18.16 | -3.10% |
| August 2026 | $12.53 | $15.02 | $18.63 | +1.37% |
| September 2026 | $13.03 | $15.70 | $19.66 | +4.56% |
| October 2026 | $13.04 | $15.81 | $19.97 | +0.69% |
| November 2026 | $13.00 | $15.83 | $20.15 | +0.16% |
| December 2026 | $13.54 | $16.57 | $21.23 | +4.65% |
Click any year to see its month-by-month IART forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IART price prediction for 2026 points to an average of $15.19 (low $8.90, high $21.23) — a potential gain of 0% on today's $15.19. A consolidation phase looks the most probable path here.
In 2027, IART is projected to trade between $13.16 and $22.83, averaging $16.80 — a potential gain of +11% from today's $15.19. That is up +11% on the projected 2026 average. Price action looks broadly range-bound.
Integra LifeSciences Holdings Corporation's 2028 outlook centres on $18.05, within a $13.70 to $25.51 range. That is up +7% on the projected 2027 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, IART could reach as high as $32.68, with a base case around $22.41 and support toward $16.57 — roughly +48% from $15.19. Momentum favours further upside here.
Expect IART to range from $19.63 to $40.68 through 2030. The $27.17 average target implies a +79% move from current prices. That is up +21% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The IART price prediction for 2031 points to an average of $29.69 (low $21.00, high $45.49) — a potential gain of +95% on today's $15.19. Momentum favours further upside here.
In 2032, IART is projected to trade between $20.49 and $46.23, averaging $29.56 — a potential gain of +95% from today's $15.19. That is 0% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Integra LifeSciences Holdings Corporation's 2033 outlook centres on $31.08, within a $21.14 to $49.53 range. That is up +5% on the projected 2032 average. That marks a +105% change versus current levels. Momentum favours further upside here.
By 2034, IART could reach as high as $53.62, with a base case around $33.08 and support toward $22.10 — roughly +118% from $15.19. Buyers look set to stay in control over this stretch.
Expect IART to range from $24.06 to $60.34 through 2035. The $36.63 average target implies a +141% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The IART price prediction for 2040 points to an average of $49.22 (low $29.88, high $86.67) — a potential gain of +224% on today's $15.19. Buyers look set to stay in control over this stretch.
In 2050, IART is projected to trade between $65.40 and $239.95, averaging $123.68 — a potential gain of +714% from today's $15.19. That is up +151% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in IART today (≈ 65.832785 IART) could be worth
$8,142.51
+$7,142.51 (+714%) by 2050 · US Dollar
Based on the average projected IART price of $123.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IARTwould be worth at today's price.
$1,000 invested in IART on May 27, 2025 (≈ 76.219513 IART) would be worth
$1,157.77
+$157.77 (+15.8%) today · 1.16× · US Dollar
Based on a IART entry price of $13.12 vs. today's $15.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.39 | $987 | -1.3% |
| 1 month ago | $10.69 | $1,420.95 | +42.1% |
| 3 months ago | $11.33 | $1,340.69 | +34.1% |
| 6 months ago | $13.12 | $1,157.77 | +15.8% |
| 1 year ago | $13.12 | $1,157.77 | +15.8% |
| All time (5.0y) ago | $68.37 | $222.17 | -77.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IART forecast.
Our base-case forecast reaches $30.00 around 2033.
Implied market cap at $30.00: $2.33B
The annual forecast presents a rising trajectory from 2026 onward, with the 2026 average price at $15.10 and a neutral sentiment. Growth accelerates in the later years, with 2029 at an average of $22.94 and 2030 at $27.56, delivering an 82.5% ROI. By 2040, the average price is forecast at $50.19 with a 232.4% ROI, and by 2050, the average price is $129.60 with a 758.3% ROI, all signaling a bullish longer-term outlook despite near-term variability.
The data also shows higher max targets in intermediate years (e.g., 2035 max $63.23) and continued bullish sentiment through 2050.
Tap a question to reveal the answer.
Year 2030 forecast: min $19.65, avg $27.56, max $41.87, ROI 82.5%, sentiment BULLISH.
The forecast shows a bullish longer-term trajectory, with rising averages and significant upside by 2030, 2040, and 2050 (e.g., 2030 avg $27.56, 2040 avg $50.19, 2050 avg $129.60) and notable ROIs (82.5% by 2030, 232.4% by 2040, 758.3% by 2050). However, near-term values vary and are not guaranteed.
Yes. The 2035 forecast shows a max of $63.23 and an average of $37.68 with a min of $24.24, indicating a potential to reach above $60 within that period.
Current price is $15.10 and market cap is $1.17B.
Thirty-day range is $12.16 to $18.74. Support is at $10.08 and resistance at $15.39.
Integra LifeSciences Holdings Corporation Community Discussion
0Share your Integra LifeSciences Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.